Furthermore, a study in 2021 demonstrated that propofol can reduce myocardial ischemia/reperfusion (I/R) injury by activating the PKC/ NRF2 pathway in H9C2 cells and the rat Langendorff model [44]. The gene discussed is NFE2L2; the disease is myocardial ischemia.